Change over period
From:
To:
Zoom:
- 3M
- 6M
- YTD
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
Helius Medical Technologies Inc Class A
NASDAQ HSDT
Data sourced from
and
and
Download Data
Helius Medical Technologies Inc Class A Share Price on June 03, 2024: USD 1.40
Helius Medical Technologies Inc Class A Share Price is USD 1.40 on June 03, 2024, a -82.61% change year over year. Share price refers to the current trading price of a single share of a company's stock. It represents the monetary value that investors are willing to pay for ownership in the company. Share prices are determined by the supply and demand dynamics in the stock market and can fluctuate throughout the trading day. Changes in share prices are influenced by various factors, including company performance, industry trends, market conditions, investor sentiment, and economic indicators. Share price is a key indicator used by investors to assess the performance and valuation of a company's stock.
-
Helius Medical Technologies Inc Class A 52-week high Share Price is USD 10.95 on July 28, 2023, which is 682.14% above the current Share Price.
-
Helius Medical Technologies Inc Class A 52-week low Share Price is USD 1.24 on May 28, 2024, which is -11.43% below the current Share Price.
-
Helius Medical Technologies Inc Class A average Share Price for the last 52 weeks is USD 6.92.
Don’t Miss A Beat
Looking to stay ahead of the competition and stay informed? Receive your daily dose of market news, trends, and analysis to kickstart your day and stay up-to-date.
NASDAQ: HSDT
| CEO | Mr. Dane Carl Andreeff |
| IPO Date | June 27, 2014 |
| Location | United States |
| Headquarters | 642 Newtown Yardley Road, Newtown, PA, United States, 18940 |
| Employees | 22 |
| Sector | Healthcare |
| Industry | Medical devices |
Description
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
Key trends
StockViz Staff
September 16, 2024
Any question? Send us an email